Non-advanced age-related macular degeneration: current concepts and future perspectives

Macular Diseases

Nonexudative Macular Neovascularization in Age-Related Macular Degeneration

JAMA Ophthalmol

Thottarath S, Gurudas S, Kubravi S, Kazantzis D, Keskin AM, Sivaprasad S, EYENEON Study Group

doi: 10.1001/jamaophthalmol.2026.0459

Macular Diseases

Diverse-Ancestry GWAS of Age-Related Macular Degeneration on 16,108 Examined Cases and 18,038 Controls

Invest Ophthalmol Vis Sci

Gorski M, Grunin M, Herold JM, Fröhlich B, Behr M, Wheeler N, Bush WS, Song YE, Zhu X, Blanton SH, Pericak-Vance MA, Heid IM, Haines JL, International Age-Related Macular Degeneration Genomics Consortium

doi: 10.1167/iovs.66.13.51

Macular Diseases

Age-Specific Increases in the Prevalence and Treatment Burden of Neovascular Age-Related Macular Degeneration in a Super-Aged Society

Invest Ophthalmol Vis Sci

Akada M, Ideyama M, Kido A, Miyata M, Ueda-Arakawa N, Tamura H, Ooto S, Miyake M, Tsujikawa A, Hata M

doi: 10.1167/iovs.67.4.19

LensesMacular Diseases

Safety and efficacy of an extended macular vision intraocular lens (IOL) for age-related macular degeneration (AMD) in real-world settings

BMC Ophthalmol

Hengerer FH, Stanzel B, Hoyos-Chacon J, Suarez M, Beckers S, Busatto P, Badalà F

doi: 10.1186/s12886-025-04515-9

Macular Diseases

Association of Mesopic and Dark-Adapted Retinal Sensitivity With Type 1 Macular Neovascularization in Age-Related Macular Degeneration

Invest Ophthalmol Vis Sci

Karaca I, Wei Y, Nelson R, Sassen SH, Daynes K, Clark F, Brown T, Messina A, Pfau M, Zhang Y, Schmitz-Valckenberg S, Fleckenstein M

doi: 10.1167/iovs.66.15.45

Macular DiseasesRetinal Diseases

Comparative diagnostic performance of six imaging modalities for detecting macular atrophy in neovascular age-related macular degeneration

Br J Ophthalmol

Olivieri C, Neri G, Ricardi F, Gelormini F, Fai A, Parisi G, Marolo P, Viggiano P, Boscia F, Reibaldi M, Borrelli E

doi: 10.1136/bjo-2025-328225

Macular Diseases

Ten-Year Incidence, Risk Factors and Progression Rate of Macular Atrophy in Neovascular Age-Related Macular Degeneration

Clin Exp Ophthalmol

Romano F, Casaluci M, Valastro A, Airaldi M, Milella P, Pozzo Giuffrida F, Cozzi E, Aretti A, Teo KY, Cheung CMG, Nassisi M, Viola F, Staurenghi G, Invernizzi A

doi: 10.1111/ceo.14608

Macular Diseases

The long-term impact of neovascular age-related macular degeneration undergoing routine treatment in first and second eyes on vision-related quality-of-life: FASBAT Report 3

Acta Ophthalmol

Airody A, Hanson RLW, Bunola-Hadfield I, Sivaprasad S, Morland AB, Chakravarthy U, Gale RP, FASBAT study group

doi: 10.1111/aos.70150

Macular Diseases

Metformin and the Development of Age-Related Macular Degeneration

JAMA Ophthalmol

Jindal DA, Hanna J, Shaia JK, Markle J, Rachitskaya A, Kaelber DC, Singh RP, Talcott KE

doi: 10.1001/jamaophthalmol.2025.3070

Related content

Nonexudative Macular Neovascularization in Age-Related Macular Degeneration

Diverse-Ancestry GWAS of Age-Related Macular Degeneration on 16,108 Examined Cases and 18,038 Controls

Age-Specific Increases in the Prevalence and Treatment Burden of Neovascular Age-Related Macular Degeneration in a Super-Aged Society

Safety and efficacy of an extended macular vision intraocular lens (IOL) for age-related macular degeneration (AMD) in real-world settings

Association of Mesopic and Dark-Adapted Retinal Sensitivity With Type 1 Macular Neovascularization in Age-Related Macular Degeneration

Comparative diagnostic performance of six imaging modalities for detecting macular atrophy in neovascular age-related macular degeneration

Ten-Year Incidence, Risk Factors and Progression Rate of Macular Atrophy in Neovascular Age-Related Macular Degeneration

The long-term impact of neovascular age-related macular degeneration undergoing routine treatment in first and second eyes on vision-related quality-of-life: FASBAT Report 3

Metformin and the Development of Age-Related Macular Degeneration